| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1011333 |
| landingPage: |
http://www.iedb.org/assay/1773004 |
| type: |
Literature
|
| publicationVenue: |
Br J Haematol
|
| dates: |
2008
|
| study type: | b cell assays |
| subject species: | Homo sapiens |
| fullName: |
Keiji Nogami
Evgueni L Saenko
Masahiro Takeyama
John C Giddings
Akira Yoshioka
Midori Shima
|
| method: |
biological activity
|
| name: |
Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372.
|
| description: |
The sequence of the epitope was provided in cited reference Healey et al. J Biol Chem 1995
270:14,505-14,509 [PMID: 7540171].
The epitope-specific anti-A2 monoclonal antibody mAb413 demonstrated a dose-dependent inhibition of thrombin-catalyzed activation of FVIII. In a separate assay, time-course of heavy chain cleavage analyzed by blotting showed that with mAb413, cleavage at R372 was markedly diminished. This was consistent with the effect of mAb413 on thrombin-catalyzed activation of the pro-co-factor and indicate that the region comprising the anti-A2 mAb epitope is likely to contain with the thrombin-interactive site(s) that affects the cleavage at R372. in the heavy chain. The Ab also inhibited the binding of A2 to Ah-thrombin.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |